报价延迟最少15分钟:2026/01/07 09:23 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-14.45/3.67
|
|
企业价值
6.66M
|
| 资产负债 |
|
每股账面净值
1.45
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
43.00K
|
|
每股收益
0.17
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms. |
